Fingerprint
Dive into the research topics of 'Survival benefit with imatinib mesylate therapy in patients with accelerated-phase chronic myelogenous leukemia - Comparison with historic experience'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically